Pemetrexed Baxter ইউরোপীয় ইউনিয়ন - ফিনিশ - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiset aineet - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Natriumklorid-Glucos Baxter Viaflo 4.5 mg/ml + 25 mg/ml infuusioneste, liuos ফিনল্যান্ড - ফিনিশ - Fimea (Suomen lääkevirasto)

natriumklorid-glucos baxter viaflo 4.5 mg/ml + 25 mg/ml infuusioneste, liuos

baxter oy - glucose monohydrate, sodium chloride - infuusioneste, liuos - 4.5 mg/ml + 25 mg/ml - elektrolyytit ja hiilihydraatit